These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 11844819)

  • 1. Increased cyclooxygenase-2 expression is associated with chemotherapy resistance and poor survival in cervical cancer patients.
    Ferrandina G; Lauriola L; Distefano MG; Zannoni GF; Gessi M; Legge F; Maggiano N; Mancuso S; Capelli A; Scambia G; Ranelletti FO
    J Clin Oncol; 2002 Feb; 20(4):973-81. PubMed ID: 11844819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concomitant radiochemotherapy plus surgery in locally advanced cervical cancer: update of clinical outcome and cyclooxygenase-2 as predictor of treatment susceptibility.
    Distefano M; Ferrandina G; Smaniotto D; Margariti AP; Zannoni G; Macchia G; Manfredi R; Mangiacotti MG; Cellini N; Scambia G
    Oncology; 2004; 67(2):103-11. PubMed ID: 15539913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic role of the ratio between cyclooxygenase-2 in tumor and stroma compartments in cervical cancer.
    Ferrandina G; Ranelletti FO; Legge F; Gessi M; Salutari V; Distefano MG; Lauriola L; Zannoni GF; Martinelli E; Scambia G
    Clin Cancer Res; 2004 May; 10(9):3117-23. PubMed ID: 15131052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of cyclooxygenase-2 is associated with a poor prognosis in patients with squamous cell carcinoma of the uterine cervix treated with radiation and concurrent chemotherapy.
    Kim YB; Kim GE; Cho NH; Pyo HR; Shim SJ; Chang SK; Park HC; Suh CO; Park TK; Kim BS
    Cancer; 2002 Aug; 95(3):531-9. PubMed ID: 12209745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclooxygenase-2 (COX-2) expression in locally advanced cervical cancer patients undergoing chemoradiation plus surgery.
    Ferrandina G; Ranelletti FO; Legge F; Lauriola L; Poerio A; Zannoni GF; Smaniotto D; Margariti PA; Macchia G; Scambia G
    Int J Radiat Oncol Biol Phys; 2003 Jan; 55(1):21-7. PubMed ID: 12504032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of cyclooxygenase-2 protein and its relationship to apoptosis in cervical carcinoma treated with neoadjuvant chemotherapy.
    Nagai N; Tian X; Mukai K; Hirata E; Kusuda T; Shiroyama Y; Shigemasa K; Ohama K
    Int J Mol Med; 2003 Nov; 12(5):709-14. PubMed ID: 14532998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aldehyde Dehydrogenase 1 Expression Predicts Chemoresistance and Poor Clinical Outcomes in Patients with Locally Advanced Cervical Cancer Treated with Neoadjuvant Chemotherapy Prior to Radical Hysterectomy.
    Xie Q; Liang J; Rao Q; Xie X; Li R; Liu Y; Zhou H; Han J; Yao T; Lin Z
    Ann Surg Oncol; 2016 Jan; 23(1):163-70. PubMed ID: 25916979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential cyclooxygenase-2 expression in squamous cell carcinoma and adenocarcinoma of the uterine cervix.
    Kim YB; Kim GE; Pyo HR; Cho NH; Keum KC; Lee CG; Seong J; Suh CO; Park TK
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):822-9. PubMed ID: 15465199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased cyclooxygenase-2 (COX-2) expression is associated with chemotherapy resistance and outcome in ovarian cancer patients.
    Ferrandina G; Lauriola L; Zannoni GF; Fagotti A; Fanfani F; Legge F; Maggiano N; Gessi M; Mancuso S; Ranelletti FO; Scambia G
    Ann Oncol; 2002 Aug; 13(8):1205-11. PubMed ID: 12181243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclooxygenase-2 (COX-2), epidermal growth factor receptor (EGFR), and Her-2/neu expression in ovarian cancer.
    Ferrandina G; Ranelletti FO; Lauriola L; Fanfani F; Legge F; Mottolese M; Nicotra MR; Natali PG; Zakut VH; Scambia G
    Gynecol Oncol; 2002 May; 85(2):305-10. PubMed ID: 11972392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synchronous coexpression of epidermal growth factor receptor and cyclooxygenase-2 in carcinomas of the uterine cervix: a potential predictor of poor survival.
    Kim GE; Kim YB; Cho NH; Chung HC; Pyo HR; Lee JD; Park TK; Koom WS; Chun M; Suh CO
    Clin Cancer Res; 2004 Feb; 10(4):1366-74. PubMed ID: 14977838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclooxygenase-2 expression in lymph node metastasis of cervical and vulvar cancer.
    Ferrandina G; Ranelletti FO; Lauriola L; Zannoni GF; Legge F; Gessi M; Salutari V; Scambia G
    Oncol Rep; 2003; 10(6):1799-804. PubMed ID: 14534699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of pre-chemotherapy hemoglobin and platelet levels in patients with stage Ib2-IIb cervical cancer treated with neoadjuvant chemotherapy followed by radical hysterectomy].
    Wang D; Wu M; Ren T; Wan XR; Feng FZ; Huang HF; Yang JX; Shen K; Xiang Y
    Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):577-81. PubMed ID: 23141176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of cyclooxygenase-2 (COX-2) in tumour and stroma compartments in cervical cancer: clinical implications.
    Ferrandina G; Lauriola L; Zannoni GF; Distefano MG; Legge F; Salutari V; Gessi M; Maggiano N; Scambia G; Ranelletti FO
    Br J Cancer; 2002 Nov; 87(10):1145-52. PubMed ID: 12402155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cyclooxygenase-2-expression in bladder cancer: tumor-biological and clinical implications].
    Wülfing C; Eltze E; Von Struensee D; Wülfing P; Bode ME; Bettendorf O; Piechota H; Hertle L
    Aktuelle Urol; 2004 Aug; 35(4):331-8. PubMed ID: 15459875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The toxicity and long-term efficacy of nedaplatin and paclitaxel treatment as neoadjuvant chemotherapy for locally advanced cervical cancer.
    Yin M; Zhang H; Li H; Li X; Liu Y; Chen X; Lou G; Li K
    J Surg Oncol; 2012 Feb; 105(2):206-11. PubMed ID: 21815150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of cyclooxygenase-2 (COX-2) in non-neoplastic and neoplastic vulvar epithelial lesions.
    Ferrandina G; Ranelletti FO; Salutari V; Gessi M; Legge F; Zannoni GF; Scambia G; Lauriola L
    Gynecol Oncol; 2004 Feb; 92(2):537-44. PubMed ID: 14766245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue microarray analysis reveals prognostic significance of COX-2 expression for local relapse in T1-2N0 larynx cancer treated with primary radiation therapy.
    Cho EI; Kowalski DP; Sasaki CT; Haffty BG
    Laryngoscope; 2004 Nov; 114(11):2001-8. PubMed ID: 15510031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anemia in patients with locally advanced cervical carcinoma administered preoperative radiochemotherapy: association with pathological response to treatment and clinical outcome.
    Ferrandina G; Distefano M; Smaniotto D; Morganti A; Paglia A; Macchia G; Corvari B; Lorusso D; Scambia G
    Gynecol Oncol; 2006 Nov; 103(2):500-5. PubMed ID: 16677692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Squamous cell carcinoma antigen: prognostic significance and role in the monitoring of neoadjuvant chemotherapy response in cervical cancer.
    Scambia G; Benedetti Panici P; Foti E; Amoroso M; Salerno G; Ferrandina G; Battaglia F; Greggi S; De Gaetano A; Puglia G
    J Clin Oncol; 1994 Nov; 12(11):2309-16. PubMed ID: 7964945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.